ROSALIND is a computer platform for realizing the promise of personalized medicine for cancer patients everywhere. ROSALIND is a dynamic, programmable computer simulation of how cell signaling pathways are altered by specific gene mutations that are associated with specific types of cancers. The underlying patent pending technology produces a comprehensive mathematical model of cell signaling and identifies optimal personalized cancer treatment options.


CHEMFirm is a revolutionary drug analysis platform based on CHEMSAS® that is positioned to rapidly and meaningfully improve the drug discovery process and improve biopharmaceutical investment performance. The system is used to identify small molecules with a pharmacological profile that increases the likelihood of success during drug development.  A series of computer simulations is used to model many important properties of the molecule. The CHEMFirm process helps medicinal chemists to be more efficient and investors make more informed decisions.